Profound Medical Corp Stock Working Capital
| PROF Stock | USD 7.33 0.23 3.24% |
Profound Medical Corp fundamentals help investors to digest information that contributes to Profound Medical's financial success or failures. It also enables traders to predict the movement of Profound Stock. The fundamental analysis module provides a way to measure Profound Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Profound Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 40.9 M | 47.3 M | |
| Change In Working Capital | 336.6 K | 353.4 K |
Profound | Working Capital |
Profound Medical Corp Company Working Capital Analysis
Profound Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Profound Medical Working Capital | 35.53 M |
Most of Profound Medical's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Profound Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Working Capital. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Profound Capital Surpluse
Capital Surpluse |
|
Based on the company's disclosures, Profound Medical Corp has a Working Capital of 35.53 M. This is 91.65% lower than that of the Health Care Equipment & Supplies sector and 97.39% lower than that of the Health Care industry. The working capital for all United States stocks is 97.6% higher than that of the company.
Profound Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in working capital category among its peers.
Profound Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Profound Medical from analyzing Profound Medical's financial statements. These drivers represent accounts that assess Profound Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Profound Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 355.5M | 230.7M | 221.9M | 177.3M | 203.9M | 252.8M | |
| Enterprise Value | 273.2M | 164.9M | 183.6M | 159.0M | 182.8M | 206.9M |
Profound Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Profound Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Profound Medical's managers, analysts, and investors.Environmental | Governance | Social |
Profound Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 192.77 M | ||||
| Shares Outstanding | 30.03 M | ||||
| Shares Owned By Insiders | 10.14 % | ||||
| Shares Owned By Institutions | 50.28 % | ||||
| Number Of Shares Shorted | 345.21 K | ||||
| Price To Book | 6.89 X | ||||
| Price To Sales | 24.50 X | ||||
| Revenue | 7.2 M | ||||
| Gross Profit | 5.57 M | ||||
| EBITDA | (26.78 M) | ||||
| Net Income | (28.57 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Short Ratio | 4.34 X | ||||
| Earnings Per Share | (1.38) X | ||||
| Target Price | 15.3 | ||||
| Number Of Employees | 131 | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 220.11 M | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Working Capital | 35.53 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
| Net Asset | 43.91 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Profound Medical Piotroski F Score and Profound Medical Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share | Quarterly Revenue Growth 0.639 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.